Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Karimi

Showing results (251-260 of 315) with videos related to

Pageof 32
Sort By:
Haematologica|January 1, 2009
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpuraRoberta Palla, Silvia Lavoretano, Rossana Lombardi, et al.
Acta Bio-Medica : Atenei Parmensis|December 6, 2023
A prospective guide for clinical implementation of selected OGTT- derived surrogate indices for the evaluation of β- cell function and insulin sensitivity in patients with transfusion-dependent β- thalassaemiaVincenzo De Sanctis, Ashraf T Soliman, Shahina Daar, et al.
Expert Review of Hematology|October 27, 2017
Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemiaVincenzo De Sanctis, Ashraf T Soliman, Heba Elsedfy, et al.
Annals of Hematology|September 2, 2008
Factor XI deficiency in Southern Iran: identification of a novel missense mutationMehran Karimi, Hamta Jafari, Saba Lahsaeizadeh, et al.
British Journal of Haematology|June 3, 2020
Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experienceMehran Karimi, Sezaneh Haghpanah, Azita Azarkeivan, et al.
Iranian Red Crescent Medical Journal|October 1, 2015
Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern IranSezaneh Haghpanah, Masoomeh Esmaeilzadeh, Naser Honar, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide studyMehran Karimi, Sezaneh Haghpanah, Tahereh Zarei, et al.
Blood Cells, Molecules & Diseases|April 22, 2019
A retrospective study on clinical manifestations of neonates with FXIII-A deficiencyMajid Naderi, Nader Cohan, Iraj Shahramian, et al.
BMC Infectious Diseases|August 3, 2021
Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center studyHadi Mottaghipisheh, Kurosh Kalantar, Ali Amanati, et al.
Journal of Pediatric Hematology/Oncology|January 26, 2017
Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With β-Thalassemia IntermediaMehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, et al.
Pageof 32

Showing results (251-260 of 315) with videos related to

Sort By:
Pageof 32
Haematologica|January 1, 2009
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpuraRoberta Palla, Silvia Lavoretano, Rossana Lombardi, et al.
Acta Bio-Medica : Atenei Parmensis|December 6, 2023
A prospective guide for clinical implementation of selected OGTT- derived surrogate indices for the evaluation of β- cell function and insulin sensitivity in patients with transfusion-dependent β- thalassaemiaVincenzo De Sanctis, Ashraf T Soliman, Shahina Daar, et al.
Expert Review of Hematology|October 27, 2017
Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemiaVincenzo De Sanctis, Ashraf T Soliman, Heba Elsedfy, et al.
Annals of Hematology|September 2, 2008
Factor XI deficiency in Southern Iran: identification of a novel missense mutationMehran Karimi, Hamta Jafari, Saba Lahsaeizadeh, et al.
British Journal of Haematology|June 3, 2020
Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experienceMehran Karimi, Sezaneh Haghpanah, Azita Azarkeivan, et al.
Iranian Red Crescent Medical Journal|October 1, 2015
Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern IranSezaneh Haghpanah, Masoomeh Esmaeilzadeh, Naser Honar, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide studyMehran Karimi, Sezaneh Haghpanah, Tahereh Zarei, et al.
Blood Cells, Molecules & Diseases|April 22, 2019
A retrospective study on clinical manifestations of neonates with FXIII-A deficiencyMajid Naderi, Nader Cohan, Iraj Shahramian, et al.
BMC Infectious Diseases|August 3, 2021
Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center studyHadi Mottaghipisheh, Kurosh Kalantar, Ali Amanati, et al.
Journal of Pediatric Hematology/Oncology|January 26, 2017
Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With β-Thalassemia IntermediaMehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, et al.
Pageof 32